Qiming U.S. Ventures Management’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Qiming U.S. Ventures Management’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,510,228	Closed	-$55.3M	–	8
2023 Q4	$55.3M	Hold	3,510,228	–	–	50.66%	1
2023 Q3	$27.2M	Hold	3,510,228	–	–	36.12%	1
2023 Q2	$34.9M	Hold	3,510,228	–	–	36.63%	1
2023 Q1	$20.4M	Hold	3,510,228	–	–	24.64%	2
2022 Q4	$27.9M	Hold	3,510,228	–	–	36.87%	1
2022 Q3	$11.1M	Hold	3,510,228	–	–	16.11%	2
2022 Q2	$20.1M	Hold	3,510,228	–	–	27.92%	1
2022 Q1	$24.7M	Hold	3,510,228	–	–	23.22%	2
2021 Q4	$80.3M	Buy	+3,510,228	New	+$90.7M	36.96%	1

Qiming U.S. Ventures Management's ICVX Position: Q1 2024 in Review

Qiming U.S. Ventures Management sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 3,510,228 shares — an estimated $55.3M sold.

Qiming U.S. Ventures Management first reported a position in ICVX in Q4 2021 and held it in 9 quarters. The position peaked at $80.3M in Q4 2021. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

Qiming U.S. Ventures Management reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Qiming U.S. Ventures Management sold 3,510,228 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $55.3M.
Qiming U.S. Ventures Management first reported a position in Icosavax, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
Qiming U.S. Ventures Management's Icosavax, Inc. Common Stock position peaked at $80.3M in Q4 2021.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Qiming U.S. Ventures Management's 13F filing for Q1 2024, filed 14 May 2024.